005 - Michael Fossel: How we age and what to do about it
Dr. Fossel is president of Telocyte, a biotech firm targeting Alzheimer’s disease, intending to begin FDA-sponsored human trials aimed at curing the underlying disease process using telomerase therapy. His latest book, The Telomerase Revolution, discusses prospective FDA clinical trials of telomerase therapy as an effective intervention for Alzheimer’s disease. His book was lauded in both The London Times and the Wall Street Journal (as one of the five best science books of 2015). It is now out in 7 languages and 10 global editions.